Findings

What do systematic reviews say?

9 questions · 9 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 55.6%GRADE not reported 0 · 0%Very low 2 · 22.2%Low 2 · 22.2%Moderate 0 · 0%High 0 · 0%

CHRONIC: ACEi or ARB vs placebo

Hypotension (ARB; withdrawn from study) · heart failure with chronic kidney disease

It is very uncertain whether CHRONIC: ACEi or ARB changes hypotension (ARB; withdrawn from study) compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
RR 2.6 [1.12, 6.07]
1 study · 332 participants
Very low

CHRONIC: ACEi or ARB vs placebo

Death (any cause) ( · heart failure with chronic kidney disease

CHRONIC: ACEi or ARB showed no clear difference in death (any cause) ( compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
RR 0.85 [0.7, 1.02]
4 studies · 5003 participants
Low

CHRONIC: ACEi or ARB vs placebo

All cardiovascular death · heart failure with chronic kidney disease

CHRONIC: ACEi or ARB showed no clear difference in cardiovascular death ( compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
RR 0.81 [0.64, 1.01]
2 studies · 1368 participants
Low

CHRONIC: ACEi or ARB vs placebo

Hospitalisation (any cause) · heart failure with chronic kidney disease

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CHRONIC: ACEi or ARB vs placebo

Heart failure hospitalisation (RR) · heart failure with chronic kidney disease

It is very uncertain whether CHRONIC: ACEi or ARB changes heart failure hospitalisation ( compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
RR 0.9 [0.43, 1.9]
2 studies · 1368 participants
Very low

CHRONIC: ACEi or ARB vs placebo

Worsening heart failure · heart failure with chronic kidney disease

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CHRONIC: ACEi or ARB vs placebo

Worsening kidney function · heart failure with chronic kidney disease

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CHRONIC: ACEi or ARB vs placebo

Hyperkalaemia · heart failure with chronic kidney disease

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CHRONIC: ACEi or ARB vs placebo

Quality of life · heart failure with chronic kidney disease

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found